News Releases

Select year
Categories

Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test

Feb 06, 2025 | Products

Read more

Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay

Feb 05, 2025 | Corporate | Pipeline

Read more

Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration

Feb 05, 2025 | Products

Read more

Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

Jan 29, 2025 | Products

Read more

Myriad Genetics Introduces Online Prenatal Genetic Testing Resource

Jan 23, 2025 | Products

Read more

Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology

Jan 21, 2025 | Products | Corporate

Read more

Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance

Jan 15, 2025 | Financial | Corporate

Read more

Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

Jan 09, 2025 | Products | Corporate

Read more

Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 08, 2025 | Corporate | Financial

Read more

MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay

Jan 07, 2025 | Products | Corporate

Read more

Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report

Jan 06, 2025 | Corporate

Read more